Abstract: Novel compounds of general formula (I), are provided with inhibitory properties for the type B botulism toxin activity, along with methods for preparation thereof and corresponding pharmaceutical compositions.
Type:
Grant
Filed:
April 10, 2002
Date of Patent:
April 17, 2007
Assignees:
Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (C.N.R.C.)
Inventors:
Bernard Roques, Christine Anne, Serge Turcaud, Marie-Claude Fournie-Zaluski